Total Payments
$486.65
2024 Payments
$209.14
Companies
10
Transactions
28
Medicare Patients
4,312
Medicare Billing
$314,535
Payment Breakdown by Category
Food & Beverage$486.65 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $486.65 | 28 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lundbeck LLC | $99.82 | 6 | $0 (2024) |
| ABBVIE INC. | $89.97 | 5 | $0 (2024) |
| GlaxoSmithKline, LLC. | $80.59 | 4 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $60.54 | 4 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $48.37 | 3 | $0 (2023) |
| Biogen, Inc. | $40.08 | 2 | $0 (2021) |
| Biohaven Pharmaceutical Holding Company Ltd. | $20.48 | 1 | $0 (2022) |
| Fidia Pharma USA Inc. | $19.18 | 1 | $0 (2022) |
| Lilly USA, LLC | $13.97 | 1 | $0 (2022) |
| ITI, Inc. | $13.65 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $209.14 | 12 | Lundbeck LLC ($83.56) |
| 2023 | $107.38 | 6 | AbbVie Inc. ($35.62) |
| 2022 | $130.05 | 8 | Otsuka America Pharmaceutical, Inc. ($29.02) |
| 2021 | $40.08 | 2 | Biogen, Inc. ($40.08) |
All Payment Transactions
28 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $15.54 | General |
| Category: PSYCHIATRY | ||||||
| 10/11/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $19.45 | General |
| Category: RESPIRATORY | ||||||
| 09/16/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $14.51 | General |
| Category: NEUROSCIENCE | ||||||
| 06/17/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $15.98 | General |
| Category: PSYCHIATRY | ||||||
| 06/13/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.97 | General |
| Category: NEUROSCIENCE | ||||||
| 05/15/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $21.14 | General |
| Category: RESPIRATORY | ||||||
| 05/10/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $18.07 | General |
| Category: PSYCHIATRY | ||||||
| 03/28/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $16.92 | General |
| Category: PSYCHIATRY | ||||||
| 03/11/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: RESPIRATORY | ||||||
| 03/01/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $17.26 | General |
| Category: PSYCHIATRY | ||||||
| 01/26/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $16.11 | General |
| Category: PSYCHIATRY | ||||||
| 01/19/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $15.20 | General |
| Category: PSYCHIATRY | ||||||
| 12/15/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $23.01 | General |
| Category: RESPIRATORY | ||||||
| 09/22/2023 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $16.26 | General |
| Category: PSYCHIATRY | ||||||
| 08/09/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.89 | General |
| Category: NEUROSCIENCE | ||||||
| 07/19/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.73 | General |
| Category: NEUROSCIENCE | ||||||
| 03/15/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.55 | General |
| Category: DIABETES | ||||||
| 01/11/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.94 | General |
| Category: DIABETES | ||||||
| 12/16/2022 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $13.65 | General |
| Category: PSYCHIATRY | ||||||
| 10/05/2022 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $14.82 | General |
| Category: PSYCHIATRY | ||||||
| 09/29/2022 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO | Food and Beverage | In-kind items and services | $13.97 | General |
| Category: Diabetes | ||||||
| 08/31/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $17.87 | General |
| Category: NEUROSCIENCE | ||||||
| 08/30/2022 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $14.20 | General |
| Category: PSYCHIATRY | ||||||
| 07/27/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $20.48 | General |
| Category: PRIMARY CARE | ||||||
| 07/13/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.88 | General |
| Category: DIABETES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 1,383 | 2,074 | $284,438 | $111,217 |
| 2022 | 22 | 1,307 | 2,019 | $242,105 | $96,237 |
| 2021 | 23 | 1,622 | 2,372 | $231,986 | $107,081 |
Total Patients
4,312
Total Services
6,465
Medicare Billing
$314,535
Procedure Codes
66
All Medicare Procedures & Services
66 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 158 | 526 | $132,552 | $49,083 | 37.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 142 | 142 | $40,044 | $18,895 | 47.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 108 | 208 | $41,683 | $13,117 | 31.5% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 109 | 109 | $11,772 | $7,768 | 66.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 22 | 29 | $9,814 | $3,810 | 38.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 116 | 117 | $3,510 | $3,440 | 98.0% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 137 | 137 | $6,576 | $2,640 | 40.1% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 130 | 130 | $7,800 | $2,505 | 32.1% |
| G0446 | Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | Office | 2023 | 80 | 80 | $5,184 | $2,116 | 40.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 29 | 38 | $6,384 | $1,658 | 26.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 11 | 11 | $4,250 | $1,278 | 30.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 106 | 175 | $1,260 | $1,228 | 97.5% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 14 | 19 | $3,055 | $924.68 | 30.3% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 45 | 70 | $2,268 | $666.40 | 29.4% |
| 90471 | Administration of vaccine | Office | 2023 | 28 | 34 | $1,550 | $522.35 | 33.7% |
| 82274 | Stool analysis for blood, by fecal hemoglobin determination by immunoassay | Office | 2023 | 30 | 31 | $1,674 | $483.60 | 28.9% |
| 82044 | Urine microalbumin (protein) analysis | Office | 2023 | 30 | 68 | $1,061 | $409.37 | 38.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 25 | 26 | $1,092 | $286.56 | 26.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 12 | 22 | $1,346 | $234.20 | 17.4% |
| 81003 | Automated urinalysis test | Office | 2023 | 39 | 53 | $445.20 | $114.40 | 25.7% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 12 | 49 | $1,117 | $38.19 | 3.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 157 | 457 | $105,546 | $41,093 | 38.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 123 | 123 | $31,960 | $16,359 | 51.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 112 | 236 | $43,387 | $14,352 | 33.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 25 | 36 | $11,280 | $4,788 | 42.5% |
About Dr. Michael Carey, M.D
Dr. Michael Carey, M.D is a Family Medicine healthcare provider based in Windsor, Colorado. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/23/2007. The National Provider Identifier (NPI) number assigned to this provider is 1760536064.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Carey, M.D has received a total of $486.65 in payments from pharmaceutical and medical device companies, with $209.14 received in 2024. These payments were reported across 28 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($486.65).
As a Medicare-enrolled provider, Carey has provided services to 4,312 Medicare beneficiaries, totaling 6,465 services with total Medicare billing of $314,535. Data is available for 3 years (2021–2023), covering 66 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Windsor, CO
- Active Since 01/23/2007
- Last Updated 01/19/2015
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1760536064
Products in Payments
- REXULTI (Drug) $160.36
- AREXVY (Drug) $80.59
- VRAYLAR (Drug) $57.59
- JARDIANCE (Drug) $48.37
- UBRELVY (Drug) $32.38
- ADUHELM (Biological) $20.68
- NURTEC ODT (Drug) $20.48
- HYM/HYN (Device) $19.18
- TRULICITY (Drug) $13.97
- CAPLYTA (Drug) $13.65
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Windsor
Dr. Timothy Madigan, M.d, M.D
Family Medicine — Payments: $5,549
Family Medicine $5,549
Dr. Amie Etters, Md, MD
Family Medicine — Payments: $5,518
Family Medicine $5,518
Neena Pursnani, Md, MD
Family Medicine — Payments: $3,223
Family Medicine $3,223
Dr. Johnny Wright, M.d., D.p.m, M.D., D.P.M
Family Medicine — Payments: $1,980
Family Medicine $1,980
Dr. Alicia Albers, Md, MD
Family Medicine — Payments: $1,883
Family Medicine $1,883
Jennifer Blair, D.o, D.O
Family Medicine — Payments: $1,150
Family Medicine $1,150